Alfaro de Maron, Ana Eloisa del Carmen – Trademark Portfolio

Entity Type: 01

Alfaro de Maron, Ana Eloisa del Carmen holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 20 filings in this category. Currently, 11 trademarks are registered. Notable registered marks include VITACOM, CRECITIN, GLOBULON, CALMATTOS, and SINESTRÉS. The owner is based in San Marcos.

Km. 4.5 Carretera a San Marcos # 428

San Marcos N/A , SV

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Alfaro de Maron, Ana Eloisa del Carmen's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (20 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Alfaro de Maron, Ana Eloisa del Carmen have?

Alfaro de Maron, Ana Eloisa del Carmen has 20 U.S. trademarks filed with the USPTO. Of these, 11 registered, 4 abandoned, 5 cancelled.

What trademark classes does Alfaro de Maron, Ana Eloisa del Carmen file in?

Alfaro de Maron, Ana Eloisa del Carmen files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Alfaro de Maron, Ana Eloisa del Carmen's most well-known trademarks?

Alfaro de Maron, Ana Eloisa del Carmen's registered trademark portfolio includes well-known marks such as VITACOM, CRECITIN, GLOBULON, CALMATTOS, and SINESTRÉS. These are among 11 currently registered trademarks in the portfolio.

What is Alfaro de Maron, Ana Eloisa del Carmen's trademark registration success rate?

Alfaro de Maron, Ana Eloisa del Carmen has a 55% trademark registration rate, with 11 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.